If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
209.00    4.00 (1.95%)
Bid:
208.50
Ask:
209.00
Spread: 0.50 (0.24%)
Market Cap: £556.21m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Director/PDMR Shareholding

23 Jun 2026 10:11

RNS Number : 4014J
Costain Group PLC
23 June 2026
Β 

Β 

Costain Group PLC (the Company)

23 June 2026

Β 

Β 

DIRECTOR/PDMR/PCA DEALING

Β 

The Company announces that Alice Vaughan PCA of Alex Vaughan, Chief Executive Officer, sold 415,015 Ordinary Shares in the Company at Β£2.063771 per share on 22 June 2026. After this sale Alex maintains an interest over 1,803,919 shares representing 673% of salary (shareholding guideline 200%).

Β 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

Notification of Dealing Form

Β 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA")

a)

Name

ALICE MARY VAUGHAN/ALEXANDER VAUGHAN

2.

Reason for the notification

a)

Position /status

PCA to CHIEF EXECUTIVE OFFICER (PDMR)

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

COSTAIN GROUP PLC

b)

LEI code

213800PKIJBZ2EDTKC88

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Β 

ORDINARY SHARES OF 1 PENCE EACH

Β 

ISIN: GB00B64NSP76

b)

Nature of the transaction

SALE OF 415,015 SHARES

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Β£2.063771

415,015

Β 

Β 

Β 

d)

Aggregated information

- Aggregated volume

- Price

Β 

N/A

Β 

e)

Date of the transaction

Β 

22 June 2026

f)

Place of the transaction

XLON

Β 

Enquiries:

Β 

Investors and analysts

Matt Jones, Costain

Β 

Matt.Jones@costain.com

+44 (0) 7860 922 341

Financial media - Headland

Andy Rivett-Carnac

Charlie Twigg

Β 

costain@headlandconsultancy.com

+44 (0) 7968 997365

+44Β (0) 7946 494568

Company Secretariat

costaincosec@costain.com

Katie Mullins

020 3922 0600

Cyd Trumper

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHSEUSUDEMSESM
Date   Source Headline
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:00 amRNSFinal Results
4th Mar 20268:27 amRNSDirectorate change
3rd Mar 202610:57 amRNSHolding(s) in Company
2nd Mar 20267:00 amRNSCostain returns to FTSE 250
25th Feb 20266:00 pmRNSAshtead Group
24th Feb 20263:59 pmRNSDirector Declaration
23rd Feb 20262:59 pmRNSHolding(s) in Company
20th Feb 20264:19 pmRNSHolding(s) in Company
18th Feb 20261:55 pmRNSHolding(s) in Company
9th Feb 20262:50 pmRNSHolding(s) in Company
9th Feb 20267:00 amRNSInvestor Presentation via Investor Meet Company
4th Feb 20266:22 pmRNSHolding(s) in Company
29th Jan 202610:17 amRNSHolding(s) in Company
28th Jan 202610:58 amRNSHolding(s) in Company
27th Jan 20267:00 amRNSCostain Awarded Contract for New M5 Junction
26th Jan 20266:27 pmRNSHolding(s) in Company
26th Jan 20267:00 amRNSNew Pension Scheme Agreement & FY25 Trading Update
23rd Jan 20263:38 pmRNSHolding(s) in Company
22nd Jan 20265:15 pmRNSHolding(s) in Company
21st Jan 20261:29 pmRNSHolding(s) in Company
16th Jan 20262:27 pmRNSHolding(s) in Company
16th Jan 20267:00 amRNSHolding(s) in Company
13th Jan 20262:49 pmRNSHolding(s) in Company
5th Jan 20263:43 pmRNSHolding(s) in Company
2nd Jan 202611:45 amRNSHolding(s) in Company
2nd Jan 202611:09 amRNSBlock listing Interim Review
31st Dec 202512:16 pmRNSHolding(s) in Company
31st Dec 202512:16 pmRNSHolding(s) in Company
30th Dec 20252:12 pmRNSHolding(s) in Company
30th Dec 20252:12 pmRNSHolding(s) in Company
29th Dec 202511:18 amRNSHolding(s) in Company
29th Dec 202511:18 amRNSHolding(s) in Company
23rd Dec 20251:41 pmRNSHolding(s) in Company
23rd Dec 20251:41 pmRNSHolding(s) in Company
22nd Dec 20259:38 amRNSHolding(s) in Company
22nd Dec 20259:38 amRNSHolding(s) in Company
19th Dec 202511:35 amRNSHolding(s) in Company
19th Dec 202511:35 amRNSHolding(s) in Company
19th Dec 20257:00 amRNSNotice of Trading Update
19th Dec 20257:00 amRNSNotice of Trading Update
18th Dec 20259:40 amRNSHolding(s) in Company
17th Dec 20254:39 pmRNSHolding(s) in Company
16th Dec 20253:40 pmRNSHolding(s) in Company
16th Dec 20253:40 pmRNSHolding(s) in Company
15th Dec 20253:49 pmRNSHolding(s) in Company
12th Dec 202512:20 pmRNSHolding(s) in Company
11th Dec 20254:15 pmRNSDirector/PDMR Shareholding
5th Dec 202511:58 amRNSHolding(s) in Company
4th Dec 202510:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.